China has pulled ahead of the United States in key areas of the life sciences, and the U.S. may only have a handful of years ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

Biotech company Colossal Biosciences said it has brought back the dire wolf, an animal that went extinct 10,000 years ago, ...

There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S.

“The de-extinction of the dire wolf and an end-to-end system for de-extinction is transformative and heralds an entirely new ...

Biotech stocks had a bad week after turmoil at the FDA, continuing a long period of underperformance after the pandemic. Many ...

Rallybio said it discontinued its RLYB212 program following disappointing results in a phase 2 trial. Pharmacokinetic data demonstrated an inability of the RLYB212 dose regimen to achieve predicted ...

Those natural essential oils you love in your skincare? More than 90% of a plant is typically discarded during the oil ...

XOMA's preferred shares (XOMAO, XOMAP) offer secure, attractive yields backed by biotech royalties, FDA-approved assets, and ...

The sophomore, a member of the honors program at the School of Environmental and Biological Sciences, is pursuing a major in ...

Analysts anticipate PDS Biotechnology to report an earnings per share (EPS) of $-0.30. Anticipation surrounds PDS ...